Evidence map›Paper›PMID 38234738›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Neuroimaging markers of patient-reported outcome measures in acute ischemic stroke.

Lara C Oliveira, Anna K Bonkhoff, Robert W Regenhardt, Kenda Alhadid, Carissa Tuozzo, Mark R Etherton, Natalia S Rost, Markus D Schirmer

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lara C OliveiraJ Philip Kistler Stroke Research Center. Department of Neurology. Massachusetts General Hospital. Harvard Medical School, Boston, MA, United States of America.
Anna K BonkhoffJ Philip Kistler Stroke Research Center. Department of Neurology. Massachusetts General Hospital. Harvard Medical School, Boston, MA, United States of America.
Robert W RegenhardtJ Philip Kistler Stroke Research Center. Department of Neurology. Massachusetts General Hospital. Harvard Medical School, Boston, MA, United States of America.
Kenda AlhadidJ Philip Kistler Stroke Research Center. Department of Neurology. Massachusetts General Hospital. Harvard Medical School, Boston, MA, United States of America.
Carissa TuozzoJ Philip Kistler Stroke Research Center. Department of Neurology. Massachusetts General Hospital. Harvard Medical School, Boston, MA, United States of America.
Mark R EthertonBiogen Inc. Stroke/Acute Neurology Neurovascular Therapeutics Development Unit. Cambridge, MA. USA.
Natalia S RostJ Philip Kistler Stroke Research Center. Department of Neurology. Massachusetts General Hospital. Harvard Medical School, Boston, MA, United States of America.
Markus D SchirmerJ Philip Kistler Stroke Research Center. Department of Neurology. Massachusetts General Hospital. Harvard Medical School, Boston, MA, United States of America.ORCID 0000-0001-9561-0239
Massachusetts General Hospital · USBiogen (United States) · US

Funding

DISCOVERY - Statistics and Analysis CoreU19NS115388 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Steven M Greenberg, Natalia S Rost · 2019 to 2026
$75.4M
Neuroscience Resident Research ProgramR25NS065743 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CASH, SYDNEY S, WILLIAMS, ZIV · 2009 to 2023
$11.8M
ERIS - Effective Reserve In StrokeR21AG083559 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI SCHIRMER, MARKUS D · 2023 to 2023
$454k
NIA NIH HHS R21 AG083559NINDS NIH HHS R25 NS065743NINDS NIH HHS U19 NS115388
6 · The paper itself

Abstract

Objectives: To determine the relationship between patient-reported outcome measures (PROMs) and volumetric imaging markers in acute ischemic stroke (AIS). Patients and Methods: Patients presenting at Massachusetts General Hospital between February 14, 2017 and February 5, 2020 with a confirmed AIS by MRI were eligible and underwent a telephone interview including PROM-10 questionnaires 3-15 months after stroke. White matter hyperintensity (V Results: Utilizing data from 167 patients (mean age: 64.7; 41.9% female), higher V Conclusions: Neuroimaging biomarkers were significantly associated with PROMs, where higher V

Identifiers

PMID38234738
PMCPMC10793527
OpenAlexW4390393272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.